| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | David G Harrison | |
| Paul J Marvar | |||
| Antony Vinh | |||
| Heinrich Lob | |||
| Faresa Zarreen | |||
| P2860 | cites work | Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide. | Q36829039 |
| Regulation of T-cell function by endogenously produced angiotensin II. | Q37100479 | ||
| Is neurogenic hypertension related to vascular inflammation of the brainstem? | Q37202058 | ||
| Role of the adaptive immune system in hypertension | Q37694853 | ||
| The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension | Q37777960 | ||
| Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease | Q37779106 | ||
| CD86 stimulation on a B cell activates the phosphatidylinositol 3-kinase/Akt and phospholipase C gamma 2/protein kinase C alpha beta signaling pathways | Q40278145 | ||
| Catecholamine influences and sympathetic neural modulation of immune responsiveness | Q40436974 | ||
| Passage of cytokines across the blood-brain barrier | Q41267787 | ||
| Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension | Q41956748 | ||
| Involvement of the brain (pro)renin receptor in cardiovascular homeostasis | Q42415303 | ||
| Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress | Q42876729 | ||
| IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine | Q43512761 | ||
| Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats | Q43852739 | ||
| Glia- and neuron-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference | Q44038776 | ||
| Superoxide mediates the actions of angiotensin II in the central nervous system. | Q44232559 | ||
| Contribution of the subfornical organ to angiotensin II-induced hypertension | Q45086329 | ||
| Sympathetic innervation of lymph nodes in mice. | Q48592305 | ||
| Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. | Q54662635 | ||
| Immune regulation and vascular inflammation in genetic hypertension | Q82377791 | ||
| Neurogenic hypertension | Q84082523 | ||
| Central and peripheral cytokines mediate immune-brain connectivity | Q84989315 | ||
| Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system | Q24655588 | ||
| The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system | Q28140631 | ||
| Neuroendocrine regulation of immunity | Q28203432 | ||
| Sympathetic nervous system overactivity and its role in the development of cardiovascular disease | Q28279754 | ||
| The sympathetic control of blood pressure | Q30440682 | ||
| A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? | Q33625889 | ||
| Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension | Q33639490 | ||
| Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 | ||
| T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats | Q33784344 | ||
| Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat. | Q33795133 | ||
| Brain microglial cytokines in neurogenic hypertension | Q34089804 | ||
| The brain renin-angiotensin system: location and physiological roles. | Q34188368 | ||
| Cardiovascular consequences of genetic variation at -6/235 in human angiotensinogen using "humanized" gene-targeted mice | Q34222317 | ||
| How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis | Q34390776 | ||
| Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo | Q34457626 | ||
| Autonomic innervation and regulation of the immune system (1987-2007) | Q34623827 | ||
| Noradrenergic and peptidergic innervation of lymphoid tissue | Q34682207 | ||
| The sensory circumventricular organs of the mammalian brain | Q35193353 | ||
| Lymphocyte responses exacerbate angiotensin II-dependent hypertension | Q35576468 | ||
| Angiotensin II revisited: new roles in inflammation, immunology and aging | Q36039299 | ||
| Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
| Brain cytokines as neuromodulators in cardiovascular control | Q36810335 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nervous system | Q9404 |
| inflammation | Q101991 | ||
| arterial hypertension | Q41861 | ||
| P304 | page(s) | 156-161 | |
| P577 | publication date | 2010-12-31 | |
| P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
| P1476 | title | The central nervous system and inflammation in hypertension | |
| P478 | volume | 11 |
| Q38667968 | A data-driven modeling approach to identify disease-specific multi-organ networks driving physiological dysregulation |
| Q36410269 | Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders |
| Q27016563 | Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases |
| Q48200626 | Brain Transforming Growth Factor-β Resists Hypertension Via Regulating Microglial Activation |
| Q26825054 | Brain inflammation and hypertension: the chicken or the egg? |
| Q90197778 | Brain perivascular macrophages contribute to the development of hypertension in stroke-prone spontaneously hypertensive rats via sympathetic activation |
| Q42479815 | Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation |
| Q34459983 | Chronic stress enhances progression of periodontitis via α1-adrenergic signaling: a potential target for periodontal disease therapy |
| Q38637276 | Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension |
| Q34323132 | Direct pro-inflammatory effects of prorenin on microglia |
| Q38110197 | Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension. |
| Q38336813 | Dysregulation of T cell subsets in the pathogenesis of hypertension |
| Q49270498 | Effects of a new nutraceutical combination on cognitive function in hypertensive patients. |
| Q41847076 | Excessive leukotriene B4 in nucleus tractus solitarii is prohypertensive in spontaneously hypertensive rats |
| Q39540875 | Inhibition of T-cell activation attenuates hypertension, TNFα, IL-17, and blood-brain barrier permeability in pregnant rats with angiogenic imbalance. |
| Q34423160 | Lectin-like ox-LDL receptor-1 (LOX-1)-Toll-like receptor 4 (TLR4) interaction and autophagy in CATH.a differentiated cells exposed to angiotensin II. |
| Q37465308 | Long-term exposure to concentrated ambient PM2.5 increases mouse blood pressure through abnormal activation of the sympathetic nervous system: a role for hypothalamic inflammation. |
| Q64235571 | Melatonin decreases M1 polarization via attenuating mitochondrial oxidative damage depending on UCP2 pathway in prorenin-treated microglia |
| Q53694150 | Neighborhood Stress and Autonomic Nervous System Activity during Sleep. |
| Q51051662 | Neural Programmatic Role of Leptin, TNFα, Melanocortin, and Glutamate in Blood Pressure Regulation vs Obesity-Related Hypertension in Male C57BL/6 Mice. |
| Q38013692 | Neurogenic hypertension: revelations from genome-wide gene expression profiling |
| Q38623987 | Neurohumoral Integration of Cardiovascular Function by the Lamina Terminalis. |
| Q36292908 | Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation |
| Q37139426 | Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. |
| Q33978310 | Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration. |
| Q47762710 | Nocturnal autonomic nervous system activity and morning proinflammatory cytokines in young adult African Americans |
| Q52674242 | Novel candidate genes important for asthma and hypertension comorbidity revealed from associative gene networks. |
| Q48414468 | Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase. |
| Q36599944 | Pivotal roles of monocytes/macrophages in stroke |
| Q26825107 | Potential clinical application of recently discovered brain mechanisms involved in hypertension |
| Q37015249 | Revelations about carotid body function through its pathological role in resistant hypertension |
| Q54487345 | Role of fibroblast growth factor signaling in vascular formation and maintenance: orchestrating signaling networks as an integrated system. |
| Q33894004 | Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension |
| Q35235496 | Sex-specific immune modulation of primary hypertension |
| Q50861734 | Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension. |
| Q39164134 | Structural and functional brain alterations in a murine model of Angiotensin II-induced hypertension |
| Q28088502 | Sympathoexcitation and arterial hypertension associated with obstructive sleep apnea and cyclic intermittent hypoxia |
| Q46644983 | The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension |
| Q37433886 | The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension |
| Q36979856 | The renin-angiotensin system in 2011: new avenues for translational research |
| Q35939300 | Vascular inflammatory cells in hypertension |
Search more.